Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (103)
  • Open Access

    REVIEW

    The Role of HPV and Hormone in Cervical Precancer and Cancer: Molecular Pathophysiology and Cell Biology of Disease and Treatment

    Pei-Yu Kao1, Jie-Hong Chen2, Kuo-Hu Chen1,3,*

    Oncology Research, Vol.34, No.6, 2026, DOI:10.32604/or.2026.078219 - 21 May 2026

    Abstract Cervical cancer remains a major global health challenge despite advances in human papillomavirus (HPV) vaccination, screening, and treatment. Persistent infection with high-risk HPV types, particularly HPV16 and HPV18, is a necessary cause of cervical cancer; however, only a small fraction of infections progress to malignancy, indicating the importance of additional cofactors. Increasing evidence identifies estrogen signaling as a critical modifier of HPV-driven carcinogenesis. Estrogen acts synergistically with HPV oncogenes E6 and E7 to promote genomic instability, immune evasion, and tumor progression, largely through effects on the tumor microenvironment (TME). This review aims to clarify and… More >

  • Open Access

    ARTICLE

    Genome-Wide Analysis of the Cinnamoyl-CoA Reductase (CCR) Gene Family in Rosa chinensis and Rosa × hybrida and Drought Stress Response of Four RhCCR Genes

    Cuifang Chang, Hua Fang, Xinfang Chen, Zhongfeng Yao, Yali Zhu, Caicai Ma, Qi Wang, Weibiao Liao*

    Phyton-International Journal of Experimental Botany, Vol.95, No.4, 2026, DOI:10.32604/phyton.2026.077290 - 28 April 2026

    Abstract The cinnamoyl-CoA reductase (CCR) gene family plays a pivotal role in lignin biosynthesis and plant stress adaptation by catalyzing the first committed step in the monolignol-specific branch of the phenylpropanoid pathway. However, a comprehensive and systematic analysis of CCRs in the economically important Rosa genus remains lacking. Here, we conducted a systematic genome-wide investigation of CCR genes in a diploid species, Rosa chinensis, and a tetraploid cultivar, Rosa × hybrida. We identified 15 and 36 non-redundant CCR genes in R. chinensis and R. × hybrida, respectively. From these, we selected 14 high-confidence orthologs of RcCCR in the R. × hybrida genome as a core… More >

  • Open Access

    ARTICLE

    Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival

    Luigi Coltelli1,2,#, Paola Orlandi3,#, Chiara Finale1,4,#, Gianna Musettini1,4,#, Luna Chiara Masini1,4, Marco Scalese5, Giulia Soria1,4, Elena Sartori1,4, Ylenia Nodari1,4, Giada Arrighi1,2, Arianna Bandini3, Marta Banchi3, Costanza Tacchi3, Donghao Tang3, Barbara Salvadori6, Lucia Tanganelli1,7, Simona Giovannelli1,8, Mirco Pistelli9, Samanta Cupini1,4, Maurizio Lucchesi1,10, Alessandro Cosimi11, Giulia Lorenzini1,7, Elisa Biasco1,4, Chiara Caparello1,4, Giulia Acconci1,4,6, Eloise Fontana1,4, Eleonora Bona1,4, Azzurra Farnesi1,4, Antonio Pellino1,4, Andrea Marini1,4, Ermelinda De Maio1,4, Irene Stasi1,4, Cecilia Barbara1,4, Enrico Sammarco1,4, Javier Rosada12,13, Giacomo Allegrini1,4,*, Guido Bocci3,*

    Oncology Research, Vol.34, No.5, 2026, DOI:10.32604/or.2026.073799 - 22 April 2026

    Abstract Background: The treatment of advanced hormone receptor-positive (HR+) breast cancer has seen relevant changes in last years. However, bevacizumab remains an option when combined with paclitaxel, but no certified pharmacogenetic profiles are now usable for the prediction of its response in breast cancer patients. This study aimed to explore the pharmacogenetic interactions among single nucleotide polymorphisms (SNPs) of genes involved in the angiogenic process and their impact on progression-free survival (PFS) and overall survival (OS) in hormone receptor-positive (HR+) metastatic breast cancer subjects administered with bevacizumab plus paclitaxel, or with paclitaxel alone (clinicaltrial.govMore >

  • Open Access

    ARTICLE

    ONX-0914 Suppresses Hormone-Sensitive Prostate Cancer by Promoting O-GlcNAcylation-Mediated Stabilization of TCF7L1

    Peng Xian1,2,#, Zhenwei Feng1,3,#, Haitao Yu3, Hubin Yin1,3, Haonan Chen1, Tenglin Shi1, Xilai Li1,3, Chunlin Zhang1,3, Xuesong Bai1,3, Xin Gou1,*, Xinyuan Li1,3,*, Jie Li1,*

    Oncology Research, Vol.34, No.4, 2026, DOI:10.32604/or.2026.073156 - 23 March 2026

    Abstract Objective: Androgen receptor (AR) signaling is a central driver of prostate cancer progression, yet the metabolic and transcriptional mechanisms regulating AR expression remain incompletely characterized. This study investigated whether the immunoproteasome inhibitor ONX-0914 suppresses hormone-sensitive prostate cancer (HSPC) through metabolic modulation of AR and aimed to identify the transcriptional mediator involved. Methods: HSPC and castration-resistant prostate cancer models were used to evaluate the effects of ONX-0914 on cell proliferation, invasion, migration, and epithelial–mesenchymal transition. Xenograft assays, bioinformatic screening, and analyses of O-GlcNAcylation and protein stability were performed, together with quantitative polymerase chain reaction (qPCR) and… More >

  • Open Access

    ARTICLE

    Real-World Outcomes of First-Line Palbociclib Plus Endocrine Therapy for HR+/HER2− Metastatic Breast Cancer in Japan: A Single-Center Retrospective Study

    Keiko Yanagihara1,*, Masato Yoshida2, Kensaku Awaji2, Tamami Yamakawa1, Sena Kato1, Miki Tamura1, Koji Nagata3

    Oncology Research, Vol.34, No.1, 2026, DOI:10.32604/or.2025.073891 - 30 December 2025

    Abstract Background: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have transformed the management of hormone receptor–positive/HER2–negative (HR+/HER2–) advanced breast cancer, yet evidence for elderly or poor-performance patients remains limited. This study examined real-world outcomes of palbociclib plus endocrine therapy in Asian patients, with additional subgroup analyses by age and performance status. Methods: We retrospectively analyzed 46 consecutive Asian patients with recurrent or de novo HR+/HER2− breast cancer treated with first-line palbociclib plus ET between April 2021 and March 2025. The primary endpoint was progression-free survival (PFS). Secondary endpoints included overall response rate (ORR), disease control rate (DCR), and safety.… More >

  • Open Access

    ARTICLE

    Synergistic Effects of Melatonin and Methyl Jasmonate in Mitigating Drought-Induced Oxidative Stress in Common Bean (Phaseolus vulgaris)

    Totan Kumar Ghosh1, Md. Roushonuzzaman Rakib1, Munna1, S. M. Zubair AL-Meraj1, Md. Moshiul Islam2, Anika Nazran1, Mohammad Golam Mostofa3,*

    Phyton-International Journal of Experimental Botany, Vol.94, No.12, pp. 3925-3943, 2025, DOI:10.32604/phyton.2025.073382 - 29 December 2025

    Abstract The productivity of common bean (Phaseolus vulgaris L.), an economically important legume, is severely hindered by drought stress. While melatonin (Mel) and methyl jasmonate (MeJA) are known to alleviate abiotic stresses, their combined effects in mitigating drought-induced oxidative stress are unknown. Here, we examined the synergistic effects of Mel and MeJA in alleviating drought-associated oxidative damage in common bean. Compared with well-watered controls, drought stress caused a significant decline in plant biomass, photosynthetic pigments, and photosystem II efficiency (Fv/Fm). Drought also significantly increased hydrogen peroxide (H2O2) accumulation, which likely contributed to membrane lipid peroxidation, as indicated by… More >

  • Open Access

    ARTICLE

    Preliminary Study on Flower Bud Differentiation and Dynamic Changes in Endogenous Hormones in ‘Hongyang’ Kiwifruit

    Xiaoqin Zheng1, Yuqing Wan1, Qian Zhang2, Liqin He2, Shihao Tang1, Qiguo Zhuang2, Lihua Wang2,*

    Phyton-International Journal of Experimental Botany, Vol.94, No.12, pp. 3879-3892, 2025, DOI:10.32604/phyton.2025.073229 - 29 December 2025

    Abstract To investigate endogenous hormone changes in “Hongyang” kiwifruit from overwintering buds to floral morphogenesis (bell-shaped flowering stage), systematic observations were conducted during the undifferentiated stage, axillary bud differentiation stage, and floral morphogenesis stage from late November 2023 to early April 2024. Paraffin sectioning was employed to examine floral bud morphology, while LC-MS targeted metabolomics quantified changes in 15 endogenous hormones across 8 classes. Results indicated floral bud differentiation commenced from late January to early February and concluded by mid-April, spanning approximately 70 days. Approximately 33 days after axillary bud initiation marked the axillary bud primordium… More >

  • Open Access

    ARTICLE

    Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis

    Anushka Ghosh, Maria J. D’Amico, Yash B. Shah, Whitney R. Smith, Mihir S. Shah, Costas D. Lallas, Alana M. Murphy*

    Canadian Journal of Urology, Vol.32, No.6, pp. 627-632, 2025, DOI:10.32604/cju.2025.067575 - 30 December 2025

    Abstract Background: Genitourinary syndrome of menopause (GSM) is a highly prevalent, underdiagnosed condition that can significantly impair quality of life (QoL). This study evaluates real-world treatment trends for GSM to better understand current management practices and highlight ongoing gaps in care. The background is in a different font than the rest of the abstract. Methods: We queried the TriNetX database for patients with a diagnosis of postmenopausal atrophic vaginitis (ICD N95.2) and treatment information from 2004–2024. A combination of RxNorm and International Classification of Diseases-10 (ICD) codes was used to classify disease and treatment type, including… More >

  • Open Access

    ARTICLE

    Adverse histological features are more commonly observed in hypergonadotropic prostate cancer patients

    Taras Shatylko1,*, Ruslan Safiullin1, Safar Gamidov1,2, Tatiana Ivanets1, Ramazan Mammaev2, Kanan Guluzade2, Ilia Rodin3, Gennadiy Sukhikh1

    Canadian Journal of Urology, Vol.32, No.6, pp. 561-568, 2025, DOI:10.32604/cju.2025.064572 - 30 December 2025

    Abstract Background: Some patients with prostate cancer have elevated gonadotropin levels. It is unknown, however, whether this condition directly influences carcinogenesis in the prostate. It is also unknown whether any specific hormone levels are useful to predict aggressive disease. The potential role of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in prostate physiology is widely discussed. The study aimed to evaluate whether patients with this endocrine pattern have different outcomes following radical prostatectomy. Methods: This was a prospective cohort study of consecutive patients undergoing robot-assisted radical prostatectomy at the Andrology and Urology Department, National Medical Research… More >

  • Open Access

    ARTICLE

    Vivipary in Festuca glauca: Analysis of Inflorescence Anatomy and Endogenous Hormones

    Hongjuan Xu1, Lan Yang1, Lejuan Shi1, Weize Wang1, Yiwen Guan1, Ye Liu1, Panpan Yang2,3,*, Zhilin Chen1,*

    Phyton-International Journal of Experimental Botany, Vol.94, No.10, pp. 3157-3173, 2025, DOI:10.32604/phyton.2025.071147 - 29 October 2025

    Abstract Vivipary in plants evolved under long-term adaptation to harsh environments and is an important reproduction pathway. However, the mechanisms driving vegetative vivipary are still unclear. In this study, we investigated the anatomy of viviparous inflorescences of Festuca glauca ‘Elijah Blue’ using stereomicroscopy and paraffin section anatomical observation. We also determined the contents of endogenous hormones in normal and viviparous inflorescences using an enzyme-linked immunosorbent assay. In viviparous inflorescences, typical upper and lower epidermal tissues, spongy tissue, and palisade tissue of leaves appeared in developmental stages 2 and 3 (20 and 45 days after emergence), indicating vegetative… More >

Displaying 1-10 on page 1 of 103. Per Page